Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Triptorelin 0.1 mg as a Luteal Phase Support in Assisted Reproductive Technique After Embryo Transfer : a Randomized Controlled Trial

NCT04087408 is registered in ClinicalTrials.gov with Moustafa Mohammed Abouelea as lead sponsor.

NCT NCT04087408
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04087408 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Triptorelin 0.1 mg as a Luteal Phase Support in Assisted Reproductive Technique After Embryo Transfer : a Randomized Controlled Trial
Lead sponsor
Moustafa Mohammed Abouelea
Phase
Phase 3
Overall status
Unknown status
Start date
April 1, 2020
Completion date
December 31, 2022
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

effect of adding gnrha as luteal phase support in antagonist art cycles